Registration
BUCHANAN INGERSOLL & ROONEY PC for GALEPHAR PHARMACEUTICAL RESEARCH INC.
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Strategy development and implementation of federal government relations initiatives relating to the Food and Drug Administrations Pre-Approval of Supplemental through New Drug Application (NDA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY COSTA New | — |
| MICHAEL P STRAZZELLA New | — |
| ELIZABETH WESTBROOK New | — |
Health Issues HCR
Strategy development and implementation of federal government relations initiatives relating to the Food and Drug Administrations Pre-Approval of Supplemental through New Drug Application (NDA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY COSTA New | — |
| MICHAEL P STRAZZELLA New | — |
| ELIZABETH WESTBROOK New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.